Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial

The aim of this study was to define the recommended dose of oxaliplatin when combined with infusional 5-fluorouracil (5-FU) and concurrent pelvic radiotherapy. Eligible patients had inoperable rectal cancer, or symptomatic primary rectal cancer with metastasis. Oxaliplatin was given on day 1 of week...

Full description

Saved in:
Bibliographic Details
Main Authors: Loi, S, Ngan, S Y K, Hicks, R J, Mukesh, B, Mitchell, P, Michael, M, Zalcberg, J, Leong, T, Lim-Joon, D, Mackay, J, Rischin, D
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2005
Subjects:
Clinical Study
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361867/
https://ncbi.nlm.nih.gov/pubmed/15700033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602413
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items